Ms. Hougen is our executive vice president of Finance and chief financial officer. As a member of our executive leadership team, Ms. Hougen contributes to the execution of our strategy, including ensuring we are well positioned to be a global, multi-product sustainably profitable company. Ionis’ finance, accounting, tax, treasury, information technology, procurement and investor relations functions report to her. Ms. Hougen joined Ionis in May 2000 as vice president, finance, and became chief accounting officer in January 2007 and chief financial officer in January 2013.
Ms. Hougen has an extensive finance and business background having held positions of increasing responsibility in numerous public companies, primarily in the life sciences industry, over her more than 25-year career. Prior to joining Ionis, Ms. Hougen was chief financial officer for Molecular Biosystems, Inc., a public biotechnology company.
In recognition of her important contributions to the financial success of Ionis, in 2018 Ms. Hougen was named a CFO of the Year by the San Diego Business Journal. Ms. Hougen received her M.B.A. from the University of San Diego and her B.A. from Franklin and Marshall College.
What is Elizabeth L. Hougen's net worth?
The estimated net worth of Elizabeth L. Hougen is at least $11.24 million as of January 30th, 2026. Ms. Hougen owns 132,881 shares of Ionis Pharmaceuticals stock worth more than $11,240,404 as of February 4th. This net worth approximation does not reflect any other assets that Ms. Hougen may own. Additionally, Ms. Hougen receives an annual salary of $1,140,000.00 as CFO at Ionis Pharmaceuticals. Learn More about Elizabeth L. Hougen's net worth.
How old is Elizabeth L. Hougen?
Ms. Hougen is currently 62 years old. There are 6 older executives and no younger executives at Ionis Pharmaceuticals. The oldest executive at Ionis Pharmaceuticals is Ms. B. Lynne Parshall Esq., J.D., Director, who is 70 years old. Learn More on Elizabeth L. Hougen's age.
What is Elizabeth L. Hougen's salary?
As the CFO of Ionis Pharmaceuticals, Inc., Ms. Hougen earns $1,140,000.00 per year. The highest earning executive at Ionis Pharmaceuticals is Dr. Brett P. Monia Ph.D., Founder, CEO & Director, who commands a salary of $2,380,000.00 per year. Learn More on Elizabeth L. Hougen's salary.
How do I contact Elizabeth L. Hougen?
Has Elizabeth L. Hougen been buying or selling shares of Ionis Pharmaceuticals?
During the last ninety days, Elizabeth L. Hougen has sold $1,553,673.96 of Ionis Pharmaceuticals stock. Most recently, Elizabeth L. Hougen sold 6,988 shares of the business's stock in a transaction on Friday, January 30th. The shares were sold at an average price of $83.24, for a transaction totalling $581,681.12. Following the completion of the sale, the executive vice president now directly owns 132,881 shares of the company's stock, valued at $11,061,014.44. Learn More on Elizabeth L. Hougen's trading history.
Who are Ionis Pharmaceuticals' active insiders?
Ionis Pharmaceuticals' insider roster includes Joseph Baroldi (EVP & Chief Business Officer), C. Bennett (EVP), Spencer Berthelsen (Director), Brian Birchler (EVP), Onaiza Cadoret-Manier (EVP), Breaux Castleman (Director), Stanley Crooke (Chairman), Shannon Devers (Executive Vice President, Chief Human Resources Officer), Allene Diaz (Director), Richard Geary (EVP), Michael Hayden (Director), Elizabeth Hougen (CFO), Kyle Jenne (Executive Vice President, Chief Global Product Strategy Officer), Joseph Klein, III (Director), Holly Kordasiewicz (Executive Vice President, Chief Development Officer), Brett Monia (CEO), Frederick Muto (Director), Patrick O'Neil (EVP), B. Parshall, Esq. (Director), Eugene Schneider (EVP), Eric Swayze (EVP), and Joseph Wender (Director). Learn More on Ionis Pharmaceuticals' active insiders.
Are insiders buying or selling shares of Ionis Pharmaceuticals?
During the last year, Ionis Pharmaceuticals insiders bought shares 1 times. They purchased a total of 15,000 shares worth more than $477,900.00. During the last year, insiders at the sold shares 76 times. They sold a total of 1,346,160 shares worth more than $89,921,385.44. The most recent insider tranaction occured on January, 30th when EVP Eric Swayze sold 6,179 shares worth more than $512,424.47. Insiders at Ionis Pharmaceuticals own 2.7% of the company.
Learn More about insider trades at Ionis Pharmaceuticals. Information on this page was last updated on 1/30/2026.
